India's Sun Pharma launches anti-baldness drug Leqselvi in US-February 2024-www.financetom.com

India's Sun Pharma launches anti-baldness drug Leqselvi in US

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

India's Sun Pharma launches anti-baldness drug Leqselvi in US

Jul 14, 2025 5:05 AM

July 14 (Reuters) - India's top drugmaker by revenue,

Sun Pharma, on Monday launched its anti-baldness drug

Leqselvi in the U.S., following settlement of a patent dispute

with Incyte Corp. ( INCY )

(Reporting by Manvi Pant; Editing by Mrigank Dhaniwala)

Previous page： BRIEF-Japan Post Holdings Co Ltd - Notice Concerning The Acquisition Of Shares Of Logisteed Holdings, Ltd. By A Subsidiary Japan Post Co Next page： BRIEF-Japan Post To Acquire Over 10% Stake In Logistics Company Logisteed, Former Hitachi Transport, Nikkei Reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Japan Post Holdings Co Ltd - Notice Concerning The Acquisition Of Shares Of Logisteed Holdings, Ltd. By A Subsidiary Japan Post Co

Oct 5, 2025

Japan Post Holdings Co Ltd ( JPHLF ): * JAPAN POST HOLDINGS CO LTD ( JPHLF ) - NOTICE CONCERNING THE ACQUISITION OF SHARES OF LOGISTEED HOLDINGS, LTD. BY A SUBSIDIARY JAPAN POST CO * JAPAN POST HOLDINGS CO LTD ( JPHLF ) - JAPAN POST TO ACQUIRE 19.9% STAKE IN LOGISTEED HOLDINGS FROM KKR * JAPAN POST HOLDINGS CO...

BRIEF-Japan Post To Acquire Over 10% Stake In Logistics Company Logisteed, Former Hitachi Transport, Nikkei Reports

Oct 5, 2025

Japan Post Holdings Co Ltd ( JPHLF ): * JAPAN POST TO ACQUIRE OVER 10% STAKE IN LOGISTICS COMPANY LOGISTEED, FORMER HITACHI TRANSPORT, NIKKEI REPORTS * JAPAN POST TO PURCHASE LOGISTEED SHARES WORTH AROUND 100 BILLION YEN FROM KKR, NIKKEI SAYS Source text: Further company coverage: ...

UK's Aston Martin forecasts fiscal 2025 earnings below market consensus

Oct 5, 2025

(Corrects to remove reference to profit in headline and paragraph 1) (Reuters) -Luxury carmaker Aston Martin said on Monday it expects its fiscal year 2025 adjusted earnings before interest and tax to come below the lower end of market consensus range, citing a challenging macroeconomic environment and the impact of tariffs. (Reporting by Raechel Thankam Job in Bengaluru; Editing by Subhranshu...

BRIEF-Shawbrook Group Considering IPO, Plans To List Ordinary Shares On LSE Main Market

Oct 5, 2025

Oct 6 (Reuters) - SHAWBROOK GROUP : * EXPECTED INTENTION TO FLOAT * CONSIDERING AN INITIAL PUBLIC OFFERING * CONSIDERING APPLYING FOR ADMISSION OF ITS ORDINARY SHARES TO EQUITY SHARES ON MAIN MARKET OF LSE * SHOULD CO PROCEED WITH IPO, OFFER WOULD COMPRISE NEW SHARES, AND EXISTING SHARES TO BE SOLD BY EXISTING SOLE SHAREHOLDER, MARLIN BIDCO * IMMEDIATELY...